Paper718154
SCE-963, a new broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.
Tsuchiya K and 5 others. Antimicrob Agents Chemother, 1978. Cited by 31 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. SCE-963, a new broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities. Papers, record 718154. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/718154
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- SCE-963, a new broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacteria | Major topic |
| Cephalosporins | Major topic |
| Animals | |
| Bacterial Infections | |
| Culture Media | |
| Dose-Response Relationship, Drug | |
| Drug Resistance, Microbial | |
| Male | |
| Mice | |
| Mice, Inbred ICR | |
| Microbial Sensitivity Tests |
Source PubMed
References8
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 13,742,934 | Microbiological studies on a new broad-spectrum penicilin, "Penbritin". | Br Med J | 1961 | https://conductscience.org/library/papers/13742934 | PubMed |
| 2 | 417,670 | SCE-129, antipseudomonal cephalosporin: in vitro and in vivo antibacterial activities. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/417670 | PubMed |
| 3 | 337,891 | Comparative effects of amoxycillin and ampicillin on the morphology of Escherichia coli in vivo and correlation with activity. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/337891 | PubMed |
| 4 | 249,623 | Comparative in vivo activities of cefsulodin, sulbenicillin, and gentamicin against Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/249623 | PubMed |
| 5 | 4,586,142 | Comparative activity of amoxycillin and ampicillin in an experimental bacterial infection in mice. | Antimicrob Agents Chemother | 1973 | https://conductscience.org/library/papers/4586142 | PubMed |
| 6 | 170,856 | Mecillinam (FL 1060), a 6beta-amidinopenicillanic acid derivative: bactericidal action and synergy in vitro. | Antimicrob Agents Chemother | 1975 | https://conductscience.org/library/papers/170856 | PubMed |
| 7 | 950,320 | CGP 9000: a new orally active, broad-spectrum cephalosporin. | J Antibiot (Tokyo) | 1976 | https://conductscience.org/library/papers/950320 | PubMed |
| 8 | 1,259,407 | Cefuroxime, a new cephalosporin antibiotic: activity in vitro. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/1259407 | PubMed |
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8,787,916 | Inhibitory effect of cephalothin on matrix metalloproteinase activity around loose hip prostheses. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8787916 | PubMed |
| 7,004,342 | Therapeutic effects of cefotiam and cefazolin on experimental pneumonia caused by Klebsiella pneumoniae DT-S in mice. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/7004342 | PubMed |
| 7,004,338 | Comparative activities of cefotiam and cefazolin against urinary tract infections with Proteus mirabilis in mice. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/7004338 | PubMed |
| 6,999,983 | Experimental respiratory tract infection with Klebsiella pneumoniae DT-S in mice: chemotherapy with kanamycin. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6999983 | PubMed |
| 6,994,642 | GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activity. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6994642 | PubMed |
| 6,969,578 | Purification and biochemical properties of beta-lactamase produced by Proteus rettgeri. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6969578 | PubMed |
| 6,968,539 | Purification and properties of a new beta-lactamase from Pseudomonas cepacia. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6968539 | PubMed |
| 6,967,295 | Activity of beta-lactamase produced by Bacteroides fragilis against newly introduced cephalosporins. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6967295 | PubMed |
| 6,941,742 | Cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6941742 | PubMed |
| 6,446,879 | Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6446879 | PubMed |
| 6,331,302 | Comparative efficacy of cefotiam versus cephalothin in the therapy of skin and soft tissue infections. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6331302 | PubMed |
| 6,297,387 | Pharmacokinetics of cefotiam in normal humans. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6297387 | PubMed |
| 6,293,976 | The effect of N-formimidoyl thienamycin, ceftazidime, cefotiam, ceftriaxone and cefotaxime on non-fermentative Gram-negative rods, Aeromonas, Plesiomonas and Enterobacter agglomerans. | Infection | 1982 | https://conductscience.org/library/papers/6293976 | PubMed |
| 6,271,094 | Nephrotoxicity of cefotiam (CGP 14221/E) in rats and rabbits. | Arch Toxicol | 1981 | https://conductscience.org/library/papers/6271094 | PubMed |
| 6,271,051 | In vitro and in vivo morphological response of Klebsiella pneumoniae to cefotiam and cefazolin. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6271051 | PubMed |
| 6,269,488 | Beta-lactamase stability and antibacterial activity of cefmenoxime (SCE-1365), a novel cephalosporin. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6269488 | PubMed |
| 6,251,749 | In vitro antimicrobial activity of cefotaxime, a new cephalosporin. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6251749 | PubMed |
| 6,097,166 | Pharmacokinetics of cefotiam administered intravenously and intramuscularly to healthy adults. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6097166 | PubMed |
| 3,865,632 | Cefotiam therapy of lower respiratory tract infections. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/3865632 | PubMed |
| 3,857,018 | Pharmacokinetics of cefotiam in humans. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/3857018 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/718154
GET https://conductscience.org/api/papers/v1/718154/cited_by?page=2